granulocytes
Granulocytes are cells in the innate immune system characterized by the presence of specific granules in their cytoplasm. Such granules distinguish them from the various agranulocytes. All myeloblastic granulocytes are polymorphonuclear, that is, they have varying shapes (morphology) of the nucleus ; and are referred to as polymorphonuclear leukocytes. In common terms, polymorphonuclear granulocyte refers specifically to "neutrophil granulocytes", the most abundant of the granulocytes; the other types have varying morphology. Granulocytes are produced via granulopoiesis in the bone marrow. — Wikipedia
Clinical trial activity
5 trials · 20 clinical orgs · 0 marketing orgs
Earliest trial started Apr 1, 2008 (NCT00627393)
Timeline
Indications
Mechanism of action
- granulocytesSupplementation
granulocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGranulocyte ↗
Also known as
- granulocyte
- granulocyte
- granulocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06240767 | Phase 1 | Nov 1, 2023 | Wuxi People's Hospital |
| NCT05425043 | N/A | Sep 14, 2021 | Children's Cancer and Leukaemia Group, University of Manchester |
| NCT04124666 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2019 | Huazhong University of Science and Technology |
| NCT00900497 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2009 | South Florida Bone Marrow/Stem Cell Transplant Institute |
| NCT00627393 | Phase 3 | Apr 1, 2008 | Cornell University, Emory University, Froedtert Memorial Lutheran Hospital, Harvard University, Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), New England Research Institutes, Puget Sound Blood Center, University of Iowa, University of Minnesota, University of Oklahoma, University of Pennsylvania, University of Pittsburgh, University of Washington, University of Wisconsin |